Screener
Wave Life Sciences WVE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 18,242 | 26,564 |
| Current portion of deferred revenue | 8,703 | 44,440 |
| Current portion of operating lease liability | 3,508 | 8,361 |
| Total current liabilities | 50,815 | 95,065 |
| Long-term liabilities: | ||
| Deferred revenue, net of current portion | 13,904 | 7,798 |
| Operating lease liability, net of current portion | 40,082 | 9,405 |
| Total long-term liabilities | 53,986 | 17,203 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's total current liabilities?
- Wave Life Sciences (WVE) reported total current liabilities of $50.82M in Q2 2026.
- How has Wave Life Sciences's total current liabilities changed year-over-year?
- Wave Life Sciences's total current liabilities decreased by 41.9% year-over-year, from $87.41M to $50.82M.
- What is the long-term trend for Wave Life Sciences's total current liabilities?
- Over 5 years (2020 to 2025), Wave Life Sciences's total current liabilities has grown at a -4.7% compound annual growth rate (CAGR), from $121.04M to $95.07M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Wave Life Sciences's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude